AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Hannover Rueck SE

Interim / Quarterly Report Aug 5, 2020

197_ip_2020-08-05_e33bb446-2dcd-47bb-9c10-1775f3482bc1.pdf

Interim / Quarterly Report

Open in Viewer

Opens in native device viewer

Conference Call on Half-yearly Report 2020

Hannover, 5 August 2020

1 Group overview 2
2 Property & Casualty reinsurance 6
3 Life & Health reinsurance 11
4 Investments 14
5 Outlook 2020 17
6 Appendix 23

Double-digit premium growth driven by increased demand for reinsurance Group net income impacted by additional reserves for Covid-19 loss estimates

| 1 Group overview | 2 | 3 | 4 | 5 | 6 |

Very strong operating cash flow driven by profitable premium growth AuM +2.4%, increasing valuation reserves overcompensates negative f/x effects

| 1 Group overview | 2 | 3 | 4 | 5 | 6 |

Shareholders' equity up by +1.5% despite dividend payment in Q2/2020 Driven by positive earnings contribution and increase in asset valuation

1 Group overview 2
2 Property & Casualty reinsurance 6
3 Life & Health reinsurance 11
4 Investments 14
5 Outlook 2020 17
6 Appendix 23

Double-digit growth in an improving market environment Underwriting result impacted by additional reserves for Covid-19 loss estimates

Property & Casualty R/I in m. EUR Q2/2019 Q2/2020 1H/2019 1H/2020
Gross written premium 3,453 4,188 7,847 9,174
Net premium earned 3,034 3,531 5,964 6,869
Net underwriting result
incl. funds withheld
71 (168) 196 (161)
Combined ratio
incl. interest on funds withheld
97.7% 104.8% 96.7% 102.3%
Net investment income from assets
under own management
252 147 476 433
Other income and expenses (1) 6 (15) 18
Operating profit/loss (EBIT) 322 (15) 657 290
Tax ratio 31.1% 306.4% 29.7% 14.8%
Group net income 212 37 431 245
Earnings per share (in EUR) 1.76 0.31 3.58 2.03

YTD

  • GWP f/x-adjusted +16.3%
  • NPE f/x-adjusted +15.0%
  • Major losses of EUR 737 m. (10.7% of NPE) exceeded budget of EUR 414 m. for 1H/2020 due to additional reserves for Covid-19 loss estimates (EUR 600 m., largely from business interruption, credit and event cancellation); combined ratio adjusted for above-budget losses at 97.6% for 1H/2020
  • Lower ordinary investment income and moderate impairments for private equity partly mitigated by higher realised gains
  • Other income and expenses increased mainly due to positive currency effects
  • EBIT margin of 4.2% below target of 10%
  • Lower tax ratio due to reduced proportion of earnings in high tax restrictions

Major losses including Covid-19 reserving exceed 1H/2020 budget of EUR 414 m. by EUR 323 m.

1) Up to 2011 claims over EUR 5 m. gross, from 2012 onwards claims over EUR 10 m. gross

Moderate major-loss expenditure apart from Covid-19-related losses

Moderate major-loss expenditure apart from Covid-19-related losses
Catastrophe losses1
)
in m. EUR
Date Gross Net
Bushfire, Australia 1 - 31 Jan 26.8 26.3
Earthquake, Puerto Rico 6 - 7 Jan 12.8 10.1
Hail / Storm, Australia 19 - 20 Jan 25.7 18.1
Storm / Flood, Australia 4 - 13 Feb 31.3 20.1
Storm "Sabine", Europe 9 - 11 Feb 24.5 18.6
Tornados, USA 2 - 5 Mar 45.2 31.1
6 Natural catastrophes 166.3 124.3
1 Property loss 12.7 12.6
1 Man-made loss 12.7 12.6
7 Major losses 179.1 136.9
Covid-19-related losses 608.5 600.1
Total 787.6 737.0

1) Natural catastrophes and other major losses in excess of EUR 10 m. gross Annual large loss budget 2020: EUR 975 m. thereof EUR 200 m. man-made and EUR 775 m. NatCat

Combined ratio above target due to additional reserves for Covid-19-related loss estimates

1H/2020: Combined Ratio vs. Target Combined Ratio

1) All lines of Property & Casualty reinsurance except those stated separately

1 Group overview 2
2 Property & Casualty reinsurance 6
3 Life & Health reinsurance 11
4 Investments 14
5 Outlook 2020 17
6 Appendix 23

Good underlying result impacted by Covid-19 losses

US mortality result otherwise in line with expectations, strong contribution from FinSol

Life & Health R/I in m. EUR Q2/2019 Q2/2020 1H/2019 1H/2020
Gross written premium 1,868 1,983 3,847 3,972
Net premium earned 1,711 1,756 3,392 3,509
Net underwriting result
incl. funds withheld
(89) (118) (138) (169)
Net investment income from
assets under own management
191 123 295 222
Other income and expenses 68 85 130 161
Operating profit/loss (EBIT) 170 90 286 214
EBIT margin 9.9% 5.1% 8.4% 6.1%
Tax ratio (0.1%) 12.2% 9.2% 11.2%
Group net income 169 78 258 188
Earnings per share (in EUR) 1.40 0.65 2.14 1.56

YTD

  • GWP f/x-adjusted +3.6%, mainly from Australia
  • NPE f/x-adjusted growth +3.8%
  • Technical result impacted by Covid-19 losses of EUR 63 m.
  • Favourable ordinary investment income and change in fair value of financial instruments. Net investment income decreased due to one-off effect in Q2/2019 (EUR 99.5 m.)
  • Other income and expenses mainly the result of strong contribution from deposit accounted treaties of EUR 173 m. (1H/2019: EUR 133 m.)

Life and health business group 1H/2020 new and pipeline business1)

1 Group overview 2
2 Property & Casualty reinsurance 6
3 Life & Health reinsurance 11
4 Investments 14
5 Outlook 2020 17
6 Appendix 23

Ordinary income decreasing in line with expectations Supporting realisations mainly from fixed-income sales

in m. EUR Q2/2019 Q2/2020 1H/2019 1H/2020 RoI
Ordinary investment income1) 376 281 702 614 2.5%
Realised gains/losses 105 38 127 140 0.6%
Impairments/appreciations & depreciations (24) (57) (41) (85) -0.4%
Change in fair value of financial
instruments (through P&L)
16 39 44 50 0.2%
Investment expenses (30) (31) (60) (63) -0.3%
NII from assets under own management 444 270 772 657 2.7%
NII from funds withheld 23 51 94 136
Total net investment income 467 321 866 793
Unrealised gains/losses of investments 31 Dec 19 30 Jun 20
On-balance sheet 1,789 2,441
thereof Fixed income AFS 1,356 2,024
Off-balance sheet 524 537
thereof Fixed income HTM, L&R 233 223
Total 2,314 2,977

1) Incl. results from associated companies

  • YTD
  • Decreasing ordinary income mainly due to inflation linkers within fixedincome securities as well as lower returns from private equity and opportunistic real estate funds; rather stable results from direct real estates; result in line with new Covid-19 expectations
  • Realised gains mainly driven by some reallocations within fixedincome portfolio and regular portfolio adjustments as well as the disposal of a real estate investment
  • Higher impairments driven by increased portion for private equity and opportunistic real estate funds' valuations as well as for alternative fixed-income funds; additional impairment on two issuers of fixedincome securities mainly recognised on emerging markets government bonds; stable depreciation on direct real estate investments
  • Rise in valuation reserves due to significantly decreasing risk-minimal yield curves overcompensating widening of credit spreads on corporates and lower valuations in the alternative spectrum

Ordinary return with lower contribution from alternative assets Credit profile slightly more defensive; modest re-entry into listed equities in Q1

1)

Investment category 2016 2017 2018 2019 Q2/2020
Fixed-income securities 87% 87% 87% 87% 87%
- Governments 28% 30% 35% 35% 35%
- Semi-governments 18% 17% 16% 15% 15%
- Corporates 33% 32% 29% 31% 30%
Investment grade 28% 27% 25% 26% 25%
Non-investment grade 4% 5% 4% 4% 5%
- Pfandbriefe, Covered bonds, ABS 9% 8% 7% 7% 2)
6%
Equities 4% 2% 2% 3% 3%
- Listed equity 2% <1% <1% <1% 1%
- Private equity 2% 2% 2% 2% 2%
Real Assets 5% 5% 6% 5% 5%
Others 1% 1% 1% 2% 2%
Short-term investments & cash 4% 4% 4% 3% 3%
Total market values in bn. EUR 42.3 40.5 42.7 48.2 49.3

Asset allocation Ordinary income split

1) Economic view based on market values without outstanding commitments for Private Equity and Alternative Real Estate as well as fixed-income investments of EUR 1,390.0 m. (EUR 1,429.9 m.) as at 30 June 2020

2) Of which Pfandbriefe and Covered Bonds = 67.0%

3) Before real estate-specific costs. Economic view based on market values as at 30 June 2020

Group overview 2
Property & Casualty reinsurance 6
Life & Health reinsurance 11
Investments 14
Outlook 2020 17
Appendix 23

Target Matrix Guidance for 2020 withdrawn due to impact from Covid-19 pandemic

Business group Key figures Initial targets for 2020 1H/2020
Group Return on investment1) ≥ 2.7% 2.8%
Return on equity2) ≥ 9.1% 7.6%
Earnings per share growth (y-o-y) ≥ 5% -39.3%
Economic value creation3) ≥ 6.1% n.a.
Solvency ratio4) ≥ 200% ⁓225%
Property & Casualty R/I Gross premium growth5) 3 - 5% 16.3%
Combined ratio6) ≤ 97% 102.3%
EBIT margin7) ≥ 10% 4.2%
xRoCA8) ≥ 2% n.a.
Life & Health R/I Gross premium growth9) 3 - 5% 3.6%
Value of New Business (VNB)10) ≥ EUR 220 m. n.a.
EBIT growth11) ≥ 5% -25.1%
xRoCA8) ≥ 2% n.a.

1) Excl. effects from ModCo derivatives; target per 1.1.2020, valid until April 21 2020 2) After tax; target: 900 bps above 5-year average return of 10-year German government bonds 3) Growth in economic equity + paid dividend; target: 600 bps above 5-year average return of 10-year German government bonds 4) According to our internal capital model and Solvency II requirements as of 30 June 2020, preliminary 5) On average throughout the R/I cycle at constant f/x rates 6) Incl. large loss budget of EUR 975 m. 7) EBIT/net premium earned 8) Excess return on allocated economic capital 9) Organic growth only; target: annual average growth over a 3-year period, at constant f/x rates 10) Based on Solvency II principles; pre-tax reporting

11) Annual average growth over a 3-year period

Improving market conditions leading to increase in P&C premium Risk-adjusted price increase in non-proportional business of 9.9%

Americas1)

  • Continued increase in premium in North America
  • Premium growth due to strong primary rate trends as well as increasingly attractive reinsurance pricing
  • Increased shares on profitable accounts led to further premium growth
  • Improved terms and conditions
  • Property: continued upward trends on rates and tightening of conditions, i.e. pandemic exclusions on exposed treaties
  • Casualty: substantially hardening R/I market with some shortage of capacity for some LoBs
  • Latin America: significant improvement in terms & conditions, especially primary rate levels; decrease in premium due to portfolio optimisation

Australia

  • Strong increase in premium due to new business and increased shares
  • Withdrawal of capacity led to improved terms and increased shares at improved pricing

Credit, surety and political risks

• Stable premium at improved pricing

Agricultural Risks: improved market conditions for both primary & R/I led to premium increase

Underwriting year figures at unchanged f/x rates (31 December 2019) 1) Excluding specialty business mentioned separately

Potential negative impacts arising mainly from P&C reinsurance

  • Expected losses for Covid-19: approx. EUR 600m (⁓80% IBNR), mainly attributable to coverages for business interruption, credit reinsurance and event cancellations
  • Knock-on effects: D&O, E&O, US casualty
  • Losses based on scenario analyses: development of pandemic, duration/severity of economic downturn, effectiveness of government stimulus
  • Manageable losses: Given our well diversified portfolio and strong reserving position
  • Claims: Moderate impact on mortality and morbidity (63MEUR as of 1H/2020). However, uncertainties remain due to the dynamic development of the pandemic
  • Excess mortality: Considerably lower in the reinsured book compared to the total population
  • Longevity: Potential positive effects from the UK

  • Ordinary investment income: Decrease mainly from alternative investments and inflation-linked bonds

  • Defaults: Only two direct defaults so far in our fixed-income portfolio. Defaults in our credit portfolio are expected to lead to impairments
  • Listed equities: Marginal investment carries unrealised gains due to entry point during crisis

  • IFRS / Economic capital: Likely to decline due to an expected decrease in OCI because the negative effect from spread widening may be higher than the benefits from reduced risk-free yields

  • Solvency II ratio: Expected to remain above 200% threshold in 2020
  • Dividends: No changes to our general policy expected

Reporting categories Volume1 ) Profitability depends on further development of Covid-19-related losses P&C financial year 2020

Regional EMEA2
)
markets Americas2
)
APAC2
)
Structured Reinsurance and ILS
Worldwide Credit, Surety and Political Risks
markets Facultative Reinsurance
Aviation and Marine
Agricultural Risks

Moderate impact on volume expected from Covid-19 pandemic L&H financial year 2020

Reporting categories Volume
Financial solutions
Longevity
Mortality
Morbidity

6 Appendix 23
5 Outlook 2020 17
4 Investments 14
3 Life & Health reinsurance 11
2 Property & Casualty reinsurance 6
1 Group overview 2

Group net income impacted by additional reserves for Covid-19 loss estimates

Group figures in m. EUR Q2/2019 Q2/2020 Δ 1H/2019 1H/2020 Δ
Gross written premium 5,321 6,171 +16.0% 11,694 13,146 +12.4%
Net premium earned 4,745 5,287 +11.4% 9,356 10,378 +10.9%
Net underwriting result (41) (336) - (36) (467) -
- Incl. funds withheld (18) (286) - 58 (330) -73.2%
Net investment income 467 321 -31.1% 866 793 -8.4%
- From assets under own mgmt. 444 271 -39.0% 772 657 -14.9%
- From funds withheld 23 51 +118.3% 94 136 +45.2%
Other income and expenses 66 92 +14.5% 113 177 +78.8%
Operating profit/loss (EBIT) 492 77 -84.4% 942 504 -46.6%
Financing costs (21) (24) +10.4% (42) (47) +11.2%
Net income before taxes 471 53 -88.7% 900 456 -49.3%
Taxes (92) 43 -146.4% (206) (51) -75.1%
Net income 379 96 -74.7% 693 405 -41.6%
- Non-controlling interests 10 (6) -157.1% 31 3 -91.6%
Group net income 369 101 -72.5% 663 402 -39.3%
Retention 90.9% 90.4% 90.6% 90.8%
EBIT margin (EBIT/Net premium earned) 10.4% 1.5% 10.1% 4.9%
Tax ratio 19.6% -80.2% 22.9% 11.3%
Earnings per share (in EUR) 3.06 0.84 5.49 3.34

Our strategic business groups at a glance 1H/2020 vs. 1H/2019

Property & Casualty R/I Life & Health R/I Total
in m. EUR 1H/2019 1H/2020 1H/2019 1H/2020 1H/2019 1H/2020
Gross written premium 7,847 9,174 3,847 3,972 11,694 13,146
Change in GWP - 16.9% - 3.3% - 12.4%
Net premium earned 5,964 6,869 3,392 3,509 9,356 10,378
Net underwriting result 173 (186) (209) (280) (36) (467)
Net underwriting result incl. funds withheld 196 (161) (138) (169) 58 (330)
Net investment income 498 459 365 333 866 793
From assets under own management 476 433 295 222 772 657
From funds withheld 23 26 71 111 94 136
Other income and expenses (15) 18 130 161 113 177
Operating profit/loss (EBIT) 657 290 286 214 942 504
Financing costs (1) (1) (1) (1) (42) (47)
Net income before taxes 656 289 285 213 900 456
Taxes (195) (43) (26) (24) (206) (51)
Net income 461 246 259 189 693 405
Non-controlling interest 30 2 1 1 31 3
Group net income 431 245 258 188 663 402
Retention 91.5% 91.4% 88.9% 89.4% 90.6% 90.8%
Combined ratio (incl. interest on funds withheld) 96.7% 102.3% - - - -
EBIT margin (EBIT / Net premium earned) 11.0% 4.2% 8.4% 6.1% 10.1% 4.9%
Tax ratio 29.7% 14.8% 9.2% 11.2% 22.9% 11.3%
Earnings per share (in EUR) 3.58 2.03 2.14 1.56 5.49 3.34

Our strategic business groups at a glance Q2/2020 vs. Q2/2019

Property & Casualty R/I Life & Health R/I Total
in m. EUR Q2/2019 Q2/2020 Q2/2019 Q2/2020 Q2/2019 Q2/2020
Gross written premium 3,453 4,188 1,868 1,983 5,321 6,171
Change in GWP - +21.3% - +5.0% - +16.0%
Net premium earned 3,034 3,531 1,711 1,756 4,745 5,287
Net underwriting result 60 (183) (101) (153) (41) (336)
Net underwriting result incl. funds withheld 71 (168) (89) (118) (18) (286)
Net investment income 263 162 203 158 467 321
From assets under own management 252 147 191 123 444 271
From funds withheld 11 15 12 36 23 51
Other income and expenses (1) 6 68 85 66 92
Operating profit/loss (EBIT) 322 (15) 170 90 492 77
Financing costs (1) (1) 0 0 (21) (24)
Net income before taxes 322 (15) 169 90 471 53
Taxes (100) 47 0 (11) (92) 43
Net income 222 31 169 79 379 96
Non-controlling interest 10 (6) 0 0 10 (6)
Group net income 212 37 169 78 369 101
Retention 90.9% 90.9% 91.0% 89.4% 90.9% 90.4%
Combined ratio (incl. interest on funds withheld) 97.7% 104.8% - - - -
EBIT margin (EBIT / Net premium earned) 10.6% -0.4% 9.9% 5.1% 10.4% 1.5%
Tax ratio 31.1% 306.4% -0.1% 12.2 % 19.6% -80.2%
Earnings per share (in EUR) 1.76 0.31 1.40 0.65 3.06 0.84

| 1 | 2 | 3 | 4 | 5 | 6 Appendix |

Stress tests on assets under own management; focus on credit exposures Current credit markets back from panic levels in an increased volatility mode

Portfolio Scenario Change in market
value
in m. EUR
Change in OCI before
tax
in m. EUR
-10% -154 -154
Equity (listed and private equity) -20% -309 -309
+50 bps -1,245 -1,184
Fixed-income securities +100 bps -2,414 -2,295
Credit spreads +50% -1,010 -1,000

High-quality fixed-income book well balanced

</bbb<>
High-quality fixed-income book well balanced
Geographical allocation mainly in accordance with our broad business diversification
Governments Semi
governments
Corporates Pfandbriefe,
Covered bonds,
ABS
Short-term
investments,
cash
Total
AAA 74% 56% 1
%
59% - 45%
A
A
12% 25% 12% 20% - 15%
A 8
%
7
%
30% 13% - 16%
BBB 4
%
1
%
45% 7
%
- 17%
<bbb< td="">2
%
11%12%1
%
-7
%
2
%
11% 12% 1
%
- 7
%
Total 100% 100% 100% 100% - 100%
Germany 19% 34% 4
%
19% 21% 17%
UK 7
%
2
%
7
%
10% 15% 7
%
France 1
%
1
%
8
%
6
%
0
%
4
%
GIIPS 0
%
1
%
4
%
5
%
0
%
2
%
Rest of Europe 3
%
14% 15% 23% 4
%
10%
USA 49% 12% 31% 14% 12% 33%
Australia 4
%
9
%
7
%
11% 11% 7
%
Asia 11% 13% 11% 2
%
24% 11%
Rest of World 5
%
14% 14% 11% 13% 10%
Total 100% 100% 100% 100% 100% 100%
Total b/s values in m. EUR 17,462 7,291 14,072 3,029 1,535 43,388

IFRS figures as at 30 June 2020

Currency allocation matches modelled liability profile Strict duration-neutral strategy continued

Currency split of investments

  • Modified duration of fixed-income mainly congruent with liabilities and currencies
  • GBP's higher modified duration predominantly due to life business; EUR driven by hybrid bond issuance
Modified duration
Q2/2020 5.8
2019 5.7
2018 4.8
2017 4.8
2016 5.0

Disclaimer

This presentation does not address the investment objectives or financial situation of any particular person or legal entity. Investors should seek independent professional advice and perform their own analysis regarding the appropriateness of investing in any of our securities.

While Hannover Re has endeavoured to include in this presentation information it believes to be reliable, complete and up-todate, the company does not make any representation or warranty, express or implied, as to the accuracy, completeness or updated status of such information.

Some of the statements in this presentation may be forward-looking statements or statements of future expectations based on currently available information. Such statements naturally are subject to risks and uncertainties. Factors such as the development of general economic conditions, future market conditions, unusual catastrophic loss events, changes in the capital markets and other circumstances may cause the actual events or results to be materially different from those anticipated by such statements.

This presentation serves information purposes only and does not constitute or form part of an offer or solicitation to acquire, subscribe to or dispose of, any of the securities of Hannover Re.

© Hannover Rück SE. All rights reserved. Hannover Re is the registered service mark of Hannover Rück SE.

Talk to a Data Expert

Have a question? We'll get back to you promptly.